Abstract
Hepatocellular carcinoma (HCC) recurs with high frequency. Characterization of recurrent HCC cells will facilitate the design of future therapeutic strategies for recurrent HCC. Two cell lines, Hep-11 and Hep-12, were established from the same HCC patient's primary and recurrent tumor tissues, respectively, and then analyzed for stem cell-like properties, immune evasion strategies and immunogenicity. Compared with Hep-11 cells, Hep-12 cells expressed higher levels of liver progenitor cell makers and displayed persistent tumorigenic potential in the serial transplantation assay. Although Hep-12 cells down-regulated human leukocyte antigen (HLA) class I expression, they could still be recognized and killed by autologous-activated tumor-infiltrating lymphocytes (TIL) in vitro. Pre-treatment with cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) increased the expression of HLA class I molecules on Hep-12 cells, and rendered them more susceptible to CD8(+) T-cell-mediated recognition and TIL-mediated cytotoxicity in vitro. Our results indicate that Hep-12 cells possess stem cell-like properties, are susceptible to autologous-activated TIL-mediated recognition and cytotoxicity, and pre-treatme...Continue Reading
References
Nov 1, 1987·Carcinogenesis·R P EvartsS S Thorgeirsson
Jul 1, 1997·Nature Medicine·D Bonnet, J E Dick
Mar 23, 2000·Journal of Hepatology·H Bismuth, P E Majno
Oct 7, 2000·Lancet·T TakayamaT Kakizoe
Aug 9, 2001·Blood·G G WulfM A Goodell
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D M ParkinP Pisani
Oct 31, 2002·Nature Immunology·Hung T Khong, Nicholas P Restifo
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
May 21, 2003·Genes & Development·Gabriela DontuMax S Wicha
Jul 5, 2003·Journal of Immunotherapy·Mark E DudleySteven A Rosenberg
Oct 7, 2003·Nature Medicine·Valerie RubioPeter P Lee
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
Nov 23, 2005·Cell Proliferation·M R Alison, M J Lovell
Feb 21, 2006·Cancer Research·Max S WichaGabriela Dontu
Jun 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tetsuhiro ChibaHideki Taniguchi
Sep 23, 2006·Cancer Research·Michael F ClarkeGeoffrey M Wahl
Nov 3, 2006·Cancer Research·Serena PellegattaGaetano Finocchiaro
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Noritoshi KobayashiSetsuo Hirohashi
Jun 16, 2007·Gastroenterology·Stephanie MaXin-Yuan Guan
Nov 16, 2007·Annals of Surgical Oncology·Gi-Hong ChoiByong-Ro Kim
Dec 18, 2007·Cell·Fengyan YuErwei Song
Feb 5, 2008·Cancer Cell·Zhen Fan YangSheung Tat Fan
Mar 28, 2008·Breast Cancer Research : BCR·Christine M Fillmore, Charlotte Kuperwasser
Mar 29, 2008·Cell Stem Cell·Jeremy N Rich, Shideng Bao
Apr 3, 2008·Cancer Research·Katja EngelmannOlivera J Finn
Nov 13, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert ThimmeHans Christian Spangenberg
Citations
Feb 11, 2015·Molecules and Cells·Lok-Hei ChanStephanie Ma
May 21, 2013·Molecular Oncology·Zhao SunRobert Chunhua Zhao
Mar 31, 2015·Epigenomics·Xiaolei ZhangFengmin Lu
Aug 28, 2014·BMC Cancer·Zhao SunRobert Chunhua Zhao
Aug 26, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yasunari Nakamoto
Apr 2, 2020·British Journal of Cancer·Yu-Man TsuiIrene Oi-Lin Ng
Jul 12, 2017·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Shigeki NakagawaHideo Baba
May 23, 2019·Cell Death & Disease·Cuiwei SunHeping Cheng
Jun 17, 2019·Biochemical Pharmacology·M ZeniouF Dantzer